Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 325 participants.
Also called NCT01699737
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 325 participants
- Sponsor
- Shionogi Inc.
- Registry
-
NCT01699737
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01699737. Randomized; quadruple masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- JTT-851
- Intervention (Drug)
- Glimepiride
- Intervention (Drug)
- Placebo for Active
- Intervention (Drug)
- Placebo for comparator
- Lead sponsor
- Shionogi Inc.
Record details
- Record id
cardio:ct-nct01699737- Content hash
c7096b056545b0e6c89563c190501e51d85ceb4fcb3b0118635be16213748c82